“The company resolved its regulatory headwinds from prior years and successfully reintroduced Zyn to its platform at a lower sourcing cost. This development, combined with strong operational execution, positions the company for high-margin growth acceleration.”
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.